Biocon reported a worse-than-expected consolidated net profit for the fourth quarter as foreign exchange losses took a bite out of the biotechnology company's earnings., more
Tuesday, April 28, 2009
Subscribe to:
Post Comments (Atom)
The lastest news and observations about doing business in Asia.
No comments:
Post a Comment